Replies to post #113856 on Biotech Values

[biomaven0]

Agreed Tarceva was an edge case, but likely PFE will terminate some promising partnerships, and if the stocks react badly there might be a buying opportunity.

Anyone know of PFE partnered products in these terminated areas?

Peter